# Coronary Artery Disease trials: 532 new since Nov 2024

Updated November 9, 2026.

532 clinical studies in Coronary Artery Disease were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 63 have an industry sponsor and 394 are recruiting or about to. The newest, NCT07926022, was posted on November 9, 2026: TAVI and PCI in Comparison to SAVR and CABG in Low and Intermediate Risk Patients With Severe Aortic Stenosis (Alexandria University).

## The full list

New Coronary Artery Disease clinical trials: 532 rows for $26.60, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 32 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/condition/coronary-artery-disease

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 532
- Industry sponsored: 63
- Recruiting or not yet: 394
- Latest posted: November 9, 2026

## Newest trials

The newest 100 of 532, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07926022 | TAVI and PCI in Comparison to SAVR and CABG in Low and Intermediate Risk Patients With Severe Aortic Stenosis | Alexandria University | Observational | Recruiting | Aortic Stenosis Disease, Coronary Artery Disease (CAD) | 100 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926022) |
| November 6, 2026 | NCT07922395 | Preoperative Gastric Ultrasound and Anaesthetic Management in Patients Undergoing Coronary Artery Bypass Grafting | Istanbul University - Cerrahpasa | Observational | Not yet recruiting | Preoperative Fasting, Pulmonary Aspiration During Anesthetic Induction, Coronary Artery Disease | 240 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922395) |
| November 5, 2026 | NCT07920575 | Assessment of Transnational Performance of the Universal Cardiac Surgical Risk Score Across International Sites | Union Health System | Observational | Not yet recruiting | Heart Valve Diseases, Cardiac Surgical Procedures, Coronary Artery Disease | 5,000 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920575) |
| November 5, 2026 | NCT07920133 | Hs-CRP-Guided Colchicine Treatment Targets in Very-High-Risk Patients With Coronary Artery Disease After PCI (TARGET-CHD) | Sir Run Run Shaw Hospital | Not applicable | Not yet recruiting | Coronary Artery Disease, Atherosclerotic Cardiovascular Disease (ASCVD), Residual Inflammatory Risk | 1,768 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920133) |
| November 5, 2026 | NCT07920055 | Sirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon... | Sir Run Run Shaw Hospital | Not applicable | Not yet recruiting | Coronary In-stent Restenosis, Coronary Artery Disease | 106 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920055) |
| November 5, 2026 | NCT07918781 | Partial Cardiac Denervation for Preventing Atrial Fibrillation After CABG | China National Center for Cardiovascular Diseases | Not applicable | Not yet recruiting | Postoperative Atrial Fibrillation, Coronary Artery Disease | 1,470 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07918781) |
| November 4, 2026 | NCT07917234 | Computational μFR-Guided Versus Angiographic Guidance in Drug-Coated Balloon Angioplasty | Centro Cardiologico Monzino | Not applicable | Recruiting | Coronary Artery Disease | 250 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07917234) |
| November 4, 2026 | NCT07916272 | Coronary Myocardial Bridge and Coronary Plaques on MDCT | Sohag University | Observational | Recruiting | Myocardial Bridging, Coronary Atherosclerosis | 50 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916272) |
| November 3, 2026 | NCT07912801 | Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass Surgery | Peking University First Hospital | Phase 4 | Not yet recruiting | Coronary Artery Disease, Coronary Artery Bypass Grafting, Hypoxia-Inducible Factor 1, Alpha Subunit, Prolyl-Hydroxylase... | 80 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912801) |
| November 3, 2026 | NCT07912541 | ADVA ACE Coronary Stent System in Coronary Artery Disease Patients (ADVANCE) | Advanced MedTech Solutions Pvt. Ltd. | Not applicable | Not yet recruiting | Coronary Artery Disease, De Novo Stenosis Lesion, Coronary Stent Implantation | 110 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912541) |
| October 27, 2026 | NCT07899021 | TRADENT Scoring Balloon Versus Non-scoring Balloon for Lesion Preparation in DCB-Based Coronary Intervention | Ulsan University Hospital | Not applicable | Not yet recruiting | Coronary Artery Disease (CAD) | 580 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07899021) |
| October 27, 2026 | NCT07898709 | Evaluating SGLT2 Inhibitors for the Reduction of No-Reflow Phenomenon in Patients Undergoing PCI | Al-Azhar University | Phase 2 | Not yet recruiting | No Reflow Phenomenon, Reperfusion Injuries, Myocardial, Myocardial Infarction, STEMI - ST Elevation Myocardial... | 100 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898709) |
| October 27, 2026 | NCT07898215 | Preoperative Gastric Ultrasound and Left Ventricular Function in Coronary Artery Bypass Surgery | Adiyaman University | Observational | Recruiting | Coronary Artery Disease, Left Ventricular Systolic Dysfunction, Gastric Contents | 50 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898215) |
| October 26, 2026 | NCT07894887 | EDIT-401 in Adults Who Require Additional Lowering of Low-Density Lipoprotein Cholesterol (LDL-C) | Editas Medicine, Inc. | Phase 1/2 | Not yet recruiting | Heterozygous Familial Hypercholesterolemia (HeFH) | 56 | Australia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07894887) |
| October 23, 2026 | NCT07892976 | The CORE Platform Trial | Copenhagen Trial Unit, Center for Clinical Intervention Research | Not applicable | Not yet recruiting | Coronary Revascularization, Coronary Artery Disease | 15,000 | Belgium, Denmark, Netherlands | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07892976) |
| October 22, 2026 | NCT07888465 | MCG Algorithm Optimization Study in Patients With Coronary Artery Stenosis | AMCG | Observational | Not yet recruiting | Coronary Artery Disease | 165 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888465) |
| October 21, 2026 | NCT07886996 | AI-Based CT Analysis of Coronary Plaque Evolution | Zhejiang Hospital | Observational | Not yet recruiting | Coronary Artery Disease | 326 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07886996) |
| October 20, 2026 | NCT07883499 | Prospective Study Protocol for Multiparametric PCCT Assessment of Early Ventricular Outcomes After CABG | Xin Lou | Observational | Recruiting | Coronary Artery Bypass Grafting (CABG) Surgery, Coronary Artery Disease | 150 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07883499) |
| October 16, 2026 | NCT07879430 | 1-Month Versus 6-Month Dual Antiplatelet Therapy After Successful Drug-Coated Balloon-Only Percutaneous Coronary Intervention | Ulsan University Hospital | Not applicable | Not yet recruiting | Coronary Artery Disease (CAD) | 1,258 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07879430) |
| October 16, 2026 | NCT07878260 | Erectile and Ejaculatory Function Following Coronary Revascularization | Saglik Bilimleri Universitesi | Observational | Completed | Erectile Dysfunction, Coronary Artery Disease, Ejaculation Disorders | 135 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07878260) |
| October 16, 2026 | NCT07877532 | Serratus Anterior Plane Block for Recovery After Minimally Invasive CABG | Chinese PLA General Hospital | Not applicable | Not yet recruiting | Postoperative Pain Control, Coronary Artery Disease | 168 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07877532) |
| October 16, 2026 | NCT07877324 | Vascular Inflammation in Atherosclerosis - Whole Body Molecular PET/CT Imaging Using Folate Receptor β | Turku University Hospital | Not applicable | Recruiting | Atheroscleroses, Inflammation | 90 | Finland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07877324) |
| October 15, 2026 | NCT07875088 | Real-World Outcomes of Drug-Coated Balloon Angioplasty in Coronary Artery Disease | Kristian Rivera | Observational | Recruiting | Coronary Artery Disease | 2,000 | Mexico, Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07875088) |
| October 14, 2026 | NCT07873879 | Modified Jailed Balloon Technique vs Jailed Wire Technique in Coronary Bifurcation Intervention | Assiut University | Not applicable | Not yet recruiting | Coronary Artery Disease | 140 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07873879) |
| October 13, 2026 | NCT07871591 | TOP-CABG Trial: Follow-up Extension (TOP-CABG FE) | China National Center for Cardiovascular Diseases | Observational | Not yet recruiting | Coronary Artery Disease, Coronary Artery Bypass Grafting, Dual Antiplatelet Therapy, Bleeding, Myocardial Ischemia... | 2,290 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871591) |
| October 13, 2026 | NCT07871201 | Dynamic Arterial Elastance for Prediction of Vasopressor Requirement After Anesthesia Induction in Elective On-Pump CABG | Elzem SEN | Observational | Recruiting | Coronary Artery Disease | 42 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871201) |
| October 13, 2026 | NCT07871188 | Association Between Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in Cardiac Surgery | Elzem SEN | Observational | Recruiting | Coronary Artery Disease | 100 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871188) |
| October 13, 2026 | NCT07870369 | Cardiovascular Risk in Patients With Primary Hyperparathyroidism | Medical University of Sofia | Observational | Completed | Heart Failure, Atrial Fibrillation (AF), Arrhythmia, Coronary Artery Disease, Hypertension (HTN) | 77 | Bulgaria | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07870369) |
| October 9, 2026 | NCT07869602 | Efficacy and Safety of the Angionix Balloon in Patients With Coronary Artery Disease Undergoing PTCA | Yonsei University | Observational | Not yet recruiting | Coronary Artery Disease | 600 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869602) |
| October 9, 2026 | NCT07868523 | The PICCOLETO XIII REVEAL-DCB Cohort A Study | Fondazione Ricerca e Innovazione Cardiovascolare ETS | Observational | Not yet recruiting | Coronary Artery Disease, Coronary Stenosis, Coronary Restenosis, Coronary Atherosclerosis, Vascular Remodeling | 200 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07868523) |
| October 8, 2026 | NCT07865377 | Serum Endogenous Estrogens, Estrogen Receptors, and Sirtuin-1 and -3 After Resveratrol Supplementation | InCor Heart Institute | Not applicable | Recruiting | Coronary Artery Disease (CAD), Menopause, Hormones | 80 | Brazil | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07865377) |
| October 8, 2026 | NCT07865364 | Coronary Sinus Reducer Objective Impact on SymptoMs, Ischaemia and miCrovascular Resistance in Non-obstructive Hypertrophic CardioMyopathy | Imperial College London | Not applicable | Not yet recruiting | Hypertrophic Cardiomyopathy | 50 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07865364) |
| October 7, 2026 | NCT07864051 | Predicting Plaque Growth Using Blood Flow Stress Markers: A Proof-of-Concept Study | Queen Mary University of London | Not applicable | Recruiting | Coronary Artery Disease (CAD) | 270 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07864051) |
| October 7, 2026 | NCT07864025 | Identification of Lesion Characteristics in Coronary Plaques Using Multimodality Intravascular Imaging and Novel Photon-counting CT in... | Queen Mary University of London | Observational | Recruiting | Coronary Artery Disease (CAD), Stable Angina Pectoris, Ischaemic Heart Disease (IHD) | 70 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07864025) |
| October 6, 2026 | NCT07860086 | On vs Off-hour PPCI in STEMI Patients | Assiut University | Observational | Not yet recruiting | Acute STEMI, PPCI, Observational Study, Coronary Artery Disease (CAD) | 450 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07860086) |
| October 5, 2026 | NCT07857031 | EXIT-CVD Project: Evidence Based Exit Strategies for the Cardiovascular Disease Continuum Trough Early Detection, Treatment and Evaluation | Centro Cardiologico Monzino | Not applicable | Active not recruiting | CAD - Coronary Artery Disease | 300 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07857031) |
| October 2, 2026 | NCT07856472 | AI-Powered Electrocardiography for Diagnosis and Prognostic Prediction in Cardiovascular Disease (AI-CVD): Multicenter Retrospective Study | Inha University Hospital | Observational | Recruiting | Cardiovascular Diseases, Coronary Artery Disease, Heart Failure, Atrial Fibrillation (AF), Ventricular Hypertrophy | 10,000 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856472) |
| October 2, 2026 | NCT07856199 | Pudendal Atherosclerosis by IVUS-NIRS in Men With Coronary Artery Disease | Hospital Central Militar | Not applicable | Recruiting | Coronary Artery Disease, Erectile Dysfunction, Atherosclerosis | 60 | Mexico | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856199) |
| October 2, 2026 | NCT07855614 | OPTIMized Diagnosis and Treatment System Based on AI and Multimodal Imaging Fusion for PCI (OPTIMAI-PCI) | Zhejiang Hospital | Not applicable | Not yet recruiting | Coronary Artery Disease | 554 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07855614) |
| October 2, 2026 | NCT07855003 | Evaluate the Clinical Efficacy and Safety of Non-Compliant PTCA Balloon Dilatation Catheter | TEDA International Cardiovascular Hospital | Observational | Completed | Coronary Artery Stenosis, Coronary Artery Disease, Coronary Balloon | 200 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07855003) |
| October 2, 2026 | NCT07853716 | REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Artery Disease Care | HeartFlow, Inc. | Not applicable | Not yet recruiting | CAD - Coronary Artery Disease | 500 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07853716) |
| October 2, 2026 | NCT07853612 | Effect of Two Weeks of Low-Dose Apixaban on Platelet Reactivity in Patients With Stable Coronary Artery Disease on Dual Antiplatelet... | The University of The West Indies | Phase 4 | Active not recruiting | Coronary Artery Disease, High On-treatment Platelet Reactivity (HTPR) | 16 | Trinidad and Tobago | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07853612) |
| October 1, 2026 | NCT07853261 | Impact of Stepwise Pressure-Increasing NC Balloon Post-Dilation on Stent Expansion | Jilin University | Not applicable | Recruiting | Coronary Artery Disease, Drug Eluting Stents | 150 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07853261) |
| October 1, 2026 | NCT07852689 | Comparison of Fractional FLOW Reserve Outcomes With Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Percutaneous Coronary... | Korea University Guro Hospital | Not applicable | Not yet recruiting | Coronary Artery Disease, Percutaneous Coronary Intervention, Drug Coated Balloon, Drug Eluting Stents (DES), Fractional... | 100 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852689) |
| September 30, 2026 | NCT07849335 | Minicrush Versus Culotte Stenting in Complex Coronary Bifurcation Lesions:The Multicenter T-REX II Registry | San Luigi Gonzaga Hospital | Observational | Enrolling by invitation | Coronary Artery Disease (CAD), Percutaneous Coronary Intervention (PCI), Bifurcation Coronary Artery Disease | 500 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07849335) |
| September 30, 2026 | NCT07849127 | wCAR-Austria: A Women-Specific Score to Assess Cardiovascular Risk in Women Aged 40 to 65 | Women's Heart Austria | Not applicable | Not yet recruiting | Cardiovascular Diseases (CVD), Coronary Artery Disease, Atheroscleroses | 800 | Austria | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07849127) |
| September 30, 2026 | NCT07848529 | Clinical Evidence With Biomarker Confirmation for PPMI in PCI Clinical Trials Study | Baim Institute for Clinical Research | Observational | Not yet recruiting | Peri-procedural Myocardial Infarction, Heart Failure Hospitalization, Mortality, Stable Angina Pectoris, Non ST... | 1,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07848529) |
| September 29, 2026 | NCT07847580 | Intranasal Dexmedetomidine and Perioperative Myocardial Injury in Patients Having Percutaneous Coronary Interventions | Second Affiliated Hospital, Zhejiang University, School of Medicine | Not applicable | Not yet recruiting | Coronary Heart Disease, Coronary Artery Disease | 2,500 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07847580) |
| September 29, 2026 | NCT07847112 | Soluble TREM-1 in Diabetes-Associated Cardiovascular Complications | Assiut University | Observational | Not yet recruiting | Type 2 Diabetes Mellitus, Cardiovascular Diseases, Coronary Artery Disease, Heart Failure, Arrhythmias, Arrhythmias... | 85 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07847112) |
| September 29, 2026 | NCT07846462 | Aspirin 50mg vs 100mg Combined With P2Y12 Inhibitor After PCI | Jilin University | Not applicable | Recruiting | Coronary Artery Disease, Acute Coronary Syndromes, Chronic Coronary Syndrome, Percutaneous Coronary Intervention | 2,640 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07846462) |
| September 25, 2026 | NCT07841847 | Effects of Personalized Cardiac Rehabilitation on miRNAs and Biochemical Biomarkers in Patients With Coronary Artery Disease | Kutahya Health Sciences University | Not applicable | Not yet recruiting | Cardiac Rehab, Coronary Artery Disease | 46 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07841847) |
| September 24, 2026 | NCT07839936 | A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease | Verve Therapeutics, Inc. | Phase 2 | Not yet recruiting | Atherosclerosis, Cardiovascular Disease, Hypercholesterolemia | 175 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07839936) |
| September 24, 2026 | NCT07839806 | Drug-coated Balloons Versus Drug-eluting Stents for de Novo Small-vessel Coronary Artery Disease | National and Kapodistrian University of Athens | Observational | Active not recruiting | Coronary Artery Disease | 230 | Greece | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07839806) |
| September 24, 2026 | NCT07837765 | Heart tEam Decision-making Assisted by Revaz AI Trial | University of Calgary | Not applicable | Not yet recruiting | Coronary Artery Disease | 712 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07837765) |
| September 22, 2026 | NCT07835178 | Post-Marketing Clinical Study of High-Pressure Cutting Balloon | BrosMed Medical Co., Ltd | Not applicable | Recruiting | Coronary Artery Disease, Calcification | 280 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07835178) |
| September 22, 2026 | NCT07834372 | REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Known Coronary Artery... | HeartFlow, Inc. | Not applicable | Not yet recruiting | CAD - Coronary Artery Disease | 350 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07834372) |
| September 22, 2026 | NCT07833384 | The Effect of Providing Genetic Risk Information on Lifestyle Behaviors in African Americans | Pennington Biomedical Research Center | Early phase 1 | Completed | Diabetes, Hypercholesterolaemia, Hypertension, Obesity Type 2 Diabetes Mellitus, Obesity & Overweight, Heart Failure... | 60 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07833384) |
| September 21, 2026 | NCT07832175 | AI-CCTA for Predicting Cardiovascular Events in CAD | Nanjing First Hospital, Nanjing Medical University | Observational | Active not recruiting | Coronary Artery Disease, Atherosclerotic Cardiovascular Disease | 3,000 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07832175) |
| September 21, 2026 | NCT07831304 | Randomized Prospective Trial on the Cost-Effectiveness of Photon-Counting CT Versus Energy-Integrating Detector CT in Suspected Chronic... | IRCCS San Raffaele | Not applicable | Recruiting | Computed Tomography Angiography, Coronary Artery Disease | 630 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07831304) |
| September 21, 2026 | NCT07830784 | Same-Day Discharge After Elective Transradial Percutaneous Coronary Intervention: A Pilot Randomized Trial | PAULO CASTRO CHERPAK | Not applicable | Completed | Coronary Artery Disease, Chronic Coronary Syndrome, Elective Percutaneous Coronary Intervention | 58 | Brazil | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07830784) |
| September 21, 2026 | NCT07830719 | Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP | Novartis Pharmaceuticals | Phase 2 | Recruiting | Coronary Artery Disease | 180 | Australia, Germany, Japan, United Kingdom, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07830719) |
| September 17, 2026 | NCT07825376 | Branching Scenario-Based Education in Coronary Artery Disease | Abant Izzet Baysal University | Not applicable | Not yet recruiting | Coronary Arterial Disease (CAD) | 54 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07825376) |
| September 16, 2026 | NCT07823400 | MIECC vs Conventional Cardiopulmonary Bypass and Systemic Inflammation in CABG | Bursa Yuksek Ihtisas Training and Research Hospital | Observational | Completed | Coronary Artery Disease, Systemic Inflammation | 90 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07823400) |
| September 16, 2026 | NCT07822737 | PCCT-Defined High-Risk Plaque and Future Coronary Events: The PREDICT Study | Beijing Chao Yang Hospital | Observational | Recruiting | Coronary Artery Disease, Plaque, Photon-Counting Computed Tomography | 500 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07822737) |
| September 16, 2026 | NCT07822581 | "Discovery2" Study of Using MCG at Emergency Departments | SB Technology, Inc. | Observational | Not yet recruiting | Acute Coronary Syndromes (ACS), Coronary Artery Disease (CAD), Chest Pain, NSTE-ACS (NSTEMI and UA) | 200 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07822581) |
| September 16, 2026 | NCT07821983 | Renal Doppler Indices for Predicting Acute Kidney Injury After Isolated CABG | Bursa Yuksek Ihtisas Training and Research Hospital | Observational | Not yet recruiting | Acute Kidney Injury, Coronary Artery Disease | 200 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07821983) |
| September 14, 2026 | NCT07817719 | Drug-Coated Balloon Only Strategy After Recanalization of Chronic Total Coronary Occlusions | University of Sao Paulo General Hospital | Not applicable | Not yet recruiting | Angina (Stable), Coronary Occlusion, Coronary Artery Disease, Chronic Total Occlusion | 38 | Brazil | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07817719) |
| September 14, 2026 | NCT07817524 | Clinical Outcome of Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention in Patients With Severe Left Ventricular... | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Active not recruiting | Coronary Artery Disease, Left Ventricular Cardiac Dysfunction | 300 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07817524) |
| September 10, 2026 | NCT07814157 | PCI Registry Basel | University Hospital, Basel, Switzerland | Observational | Recruiting | Coronary Artery Disease, Coronary Stenosis, Coronary Occlusion | 10,000 | Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07814157) |
| September 10, 2026 | NCT07813195 | Assessment of Erectile Dysfunction and Coronary Artery Disease Severity | Assiut University | Observational | Not yet recruiting | Erectile Dysfunction and Coronary Artery Disease | 120 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07813195) |
| September 9, 2026 | NCT07811102 | Hospital-to-Home Transitional Cardiac Rehabilitation After Cardiac Surgery | Cheng-Hsin General Hospital | Not applicable | Completed | Telerehabilitation, Cardiac Rehabilitation, Cardiac Surgical Procedures, Heart Valve Diseases, Coronary Artery Disease | 30 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07811102) |
| September 9, 2026 | NCT07811024 | First-in-Human Study Using the SiroMax™ Sirolimus-Coated Balloon Catheter as a Percutaneous Transluminal Coronary Angioplasty (PTCA)... | Tonic Medical, Inc. | Not applicable | Recruiting | Coronary Artery Disease, Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart... | 60 | Uzbekistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07811024) |
| September 9, 2026 | NCT07808593 | Artificial Intelligence - Based Opportunistic Coronary Artery Calcium Scoring on Routine Chest-CT Scan | University of Cologne | Observational | Not yet recruiting | Coronary Artery Calcification, Cardiovascular Risk, Coronary Artery Disease, End-Stage Renal Disease Requiring... | 1,950 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07808593) |
| September 4, 2026 | NCT07803679 | A Trial Assessing the Effectiveness of Evolocumab in Reducing the Plaque Burden in Participants With Subclinical Atheroma | Amgen | Phase 4 | Not yet recruiting | Coronary Artery Disease, Hypercholesterolemia, Atheroma, Atherosclerotic Plaque | 308 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07803679) |
| September 2, 2026 | NCT07800741 | Flow-Controlled vs. Pressure-Controlled Ventilation in CABG: Effects on Lung Aeration and Diaphragm Function | Koşuyolu Kartal Heart Training and Research Hospital | Not applicable | Not yet recruiting | Coronary Artery Disease, Postoperative Pulmonary Complications, Pulmonary Atelectasis, Postoperative, Diaphragm... | 154 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07800741) |
| September 1, 2026 | NCT07797179 | Effect of Cold Application on Pain, Ecchymosis, and Comfort After Transradial Coronary Angiography | Bezmialem Vakif University | Not applicable | Completed | Coronary Artery Disease | 104 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07797179) |
| September 1, 2026 | NCT07796750 | Extensive BITA Grafting in the Canary Islands: an IPTW Analysis | Hospital Universitario de Gran Canaria Doctor Negrín | Observational | Completed | Coronary Artery Disease, Coronary Artery Bypass Grafting, Myocardial Revascularization | 666 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07796750) |
| September 1, 2026 | NCT07796217 | Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy | Seoul National University Bundang Hospital | Phase 4 | Recruiting | Cardiac Event, Coronary Artery Disease, Peripheral Artery Disease, Bleeding | 2,758 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07796217) |
| August 31, 2026 | NCT07795645 | Validating a Medical AI Fine-Tuning Platform for Major Diseases | Beijing Friendship Hospital | Observational | Recruiting | Chronic Gastritis, Gastric Cancer (GC), Coronary Artery Disease, Stroke, Gastro Esophageal Reflux | 96,000 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07795645) |
| August 31, 2026 | NCT07794839 | Drug-coated Balloon Treatment | Istanbul Mehmet Akif Ersoy Educational and Training Hospital | Observational | Recruiting | Coronary Artery Disease | 1,000 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07794839) |
| August 26, 2026 | NCT07787364 | Intraoperative Targeted Versus Liberal Blood Pressure Management in Patients Undergoing Off-pump Coronary Artery Bypass Grafting | Chinese Academy of Medical Sciences, Fuwai Hospital | Not applicable | Not yet recruiting | Coronary Artery Disease, Postoperative Complications | 416 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07787364) |
| August 25, 2026 | NCT07784049 | The Correlation Between Sodium Urate (MSU) Deposition and Coronary Atherosclerosis in Patients With Foot Gout | The Affiliated Hospital of Qingdao University | Observational | Not yet recruiting | Gout, Coronary Atheroma | 200 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07784049) |
| August 24, 2026 | NCT07781436 | A Randomized Controlled Trial: Fuzheng Yangxin Formula for ERAS After CABG | Peking University Third Hospital | Not applicable | Not yet recruiting | CAD - Coronary Artery Disease, CABG, ERAS, Medicine, Chinese Traditional | 230 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07781436) |
| August 20, 2026 | NCT07777341 | Study Evaluating the Effects of Red Grape Juice Consumption on Metabolism in Men With Coronary Artery Disease | University of Sao Paulo General Hospital | Not applicable | Recruiting | Coronary Arterial Disease (CAD) | 50 | Brazil | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07777341) |
| August 20, 2026 | NCT07775742 | Effect of High-Intensity Interval Training Versus Home-Based Rehabilitation Program On Patients Underwent Coronary Artery Bypass Graft... | Kafrelsheikh University | Not applicable | Recruiting | Coronary Artery Disease, Coronary Graft Stenosis | 84 | Saudi Arabia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775742) |
| August 19, 2026 | NCT07773870 | Cold-Region Exposure and Cardiac Remodeling After PCI | Chinese PLA General Hospital | Observational | Recruiting | Coronary Artery Disease, Percutaneous Coronary Intervention (PCI), Left Ventricular Remodeling, Cold Exposure | 400 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07773870) |
| August 19, 2026 | NCT07773064 | Identification for High Risk of Coronary Heart Disease Based on Quantitative Analysis of Fundus Vessels and Metabolic Molecules | Beijing Hospital | Observational | Recruiting | Coronary Artery Disease | 3,000 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07773064) |
| August 18, 2026 | NCT07771127 | HEMOSTATİC PAD AND SANDBAG | Uludag University | Not applicable | Recruiting | Coronary Artery Disease, Coronary Angiography, Vascular Access Site Complications | 480 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07771127) |
| August 17, 2026 | NCT07769008 | CCTA-Based vs CAG-Based CABG: A Multicenter Pragmatic Non-Inferiority Trial | Ruijin Hospital | Not applicable | Recruiting | Coronary Artery Disease, Coronary Artery Bypass Grafting, Coronary Computed Tomography Angiography, Coronary... | 826 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07769008) |
| August 17, 2026 | NCT07768020 | Effect of Eye Mask Use on Sleep Quality and Delirium After CABG Surgery | Munzur University | Not applicable | Not yet recruiting | Coronary Artery Disease, Sleep Quality, Postoperative Delirium (POD) | 100 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07768020) |
| August 14, 2026 | NCT07766434 | A Prospective Multicenter Real-World Registry of Quantitative Flow Ratio-Guided Coronary REvascularization and QuAlity evaLuation | China National Center for Cardiovascular Diseases | Observational | Recruiting | Coronary Artery Disease | 10,000 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07766434) |
| August 13, 2026 | NCT07764094 | Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery Disease | Nanjing First Hospital, Nanjing Medical University | Observational | Recruiting | PCI, Drug-coated Balloon, Coronary Artery Disease | 500 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07764094) |
| August 13, 2026 | NCT07764081 | Progression, Management, and Clinical Outcomes of Coronary Artery Aneurysms | Nanjing First Hospital, Nanjing Medical University | Observational | Recruiting | Coronary Artery Disease, Aneurysms, Coronary Intervention | 1,000 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07764081) |
| August 13, 2026 | NCT07763769 | Validation of the MedHub AutocathFFR Software Device for Non-Invasive Fractional Flow Reserve (FFR) | Medhub Ltd. | Observational | Completed | Coronary Artery Disease, Stable Angina, Unstable Angina, Non-ST-Elevation Myocardial Infarction | 277 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07763769) |
| August 13, 2026 | NCT07762898 | Sedentary Behavior Intervention for Older Adults With Coronary Heart Disease and Frailty | Gansu University of Chinese Medicine | Not applicable | Not yet recruiting | Coronary Artery Disease, Sedentary Behavior, Prefrailty | 64 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07762898) |
| August 13, 2026 | NCT07762755 | Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT | China National Center for Cardiovascular Diseases | Phase 4 | Not yet recruiting | Coronary Artery Disease, Hyperlipidaemia, Hypertriglyceridaemia, Coronary Atherosclerosis | 100 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07762755) |
| August 12, 2026 | NCT07761728 | The FLARE (Flurpiridaz vs. Rubidium Evaluation) Trial | University of California, Los Angeles | Observational | Enrolling by invitation | Coronary Artery Disease, Coronary Microvascular Disease | 60 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07761728) |
| August 12, 2026 | NCT07761624 | Turkish Chronic Total Occlusion Percutaneous Coronary Intervention Registry | Ahmet Seyfeddin Gürbüz | Observational | Not yet recruiting | Chronic Total Occlusion (CTO), Coronary Artery Disease | 70,000 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07761624) |
| August 12, 2026 | NCT07760129 | Erector Spinae Oxygen Saturation and AKI After OPCAB | Yonsei University | Observational | Not yet recruiting | Acute Kidney Injury, Coronary Artery Disease, Coronary Artery Bypass, Off-Pump, Postoperative Complications, Cardiac... | 138 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07760129) |
| August 7, 2026 | NCT07753031 | Non-Interventional Study of Ferretab® Comp. (Ferrous Fumarate + Folic Acid Prolonged-Release Capsules) Effects in Adult Patients With Iron... | Alcea | Observational | Not yet recruiting | Iron Deficiency Anemia, Coronary Artery Disease, Heart Failure With Preserved Ejection Fraction (HFPEF) | 389 | Russia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753031) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| China National Center for Cardiovascular Diseases | 22 | November 5, 2026 |
| Assiut University | 9 | October 14, 2026 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 7 | September 29, 2026 |
| Yonsei University | 6 | October 9, 2026 |
| Ruijin Hospital | 6 | August 17, 2026 |
| Beijing Anzhen Hospital | 6 | August 6, 2026 |
| Fundación EPIC | 6 | February 10, 2026 |
| Nanjing First Hospital, Nanjing Medical University | 5 | September 21, 2026 |
| Shanghai Zhongshan Hospital | 5 | May 29, 2026 |
| Samsung Medical Center | 5 | March 2, 2026 |
| University of Florida | 5 | November 10, 2025 |
| Chinese PLA General Hospital | 4 | October 16, 2026 |
| HeartFlow, Inc. | 4 | October 2, 2026 |
| San Luigi Gonzaga Hospital | 4 | September 30, 2026 |
| University of Calgary | 4 | September 24, 2026 |
| University of Sao Paulo General Hospital | 4 | September 14, 2026 |
| Xijing Hospital | 4 | January 30, 2026 |
| Cairo University | 4 | December 5, 2025 |
| Istanbul University - Cerrahpasa | 3 | November 6, 2026 |
| Centro Cardiologico Monzino | 3 | November 4, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 253 | November 5, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 217 | November 9, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 32 | November 3, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 15 | October 27, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 10 | June 1, 2026 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 4 | October 26, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 1 | September 22, 2026 |

## By country

| Country | New trials | Latest |
| --- | --- | --- |
| [China](https://specstream.ai/data/clinical-trials/country/china) | 116 | November 5, 2026 |
| [United States](https://specstream.ai/data/clinical-trials/country/united-states) | 54 | October 2, 2026 |
| [Turkey (Türkiye)](https://specstream.ai/data/clinical-trials/country/turkey-t-rkiye) | 51 | November 6, 2026 |
| [South Korea](https://specstream.ai/data/clinical-trials/country/south-korea) | 24 | October 9, 2026 |
| [Spain](https://specstream.ai/data/clinical-trials/country/spain) | 19 | October 15, 2026 |
| [United Kingdom](https://specstream.ai/data/clinical-trials/country/united-kingdom) | 19 | October 8, 2026 |
| [Italy](https://specstream.ai/data/clinical-trials/country/italy) | 17 | November 4, 2026 |
| [Egypt](https://specstream.ai/data/clinical-trials/country/egypt) | 15 | November 9, 2026 |
| [Russia](https://specstream.ai/data/clinical-trials/country/russia) | 15 | August 7, 2026 |
| [Netherlands](https://specstream.ai/data/clinical-trials/country/netherlands) | 14 | October 23, 2026 |
| [Brazil](https://specstream.ai/data/clinical-trials/country/brazil) | 14 | October 8, 2026 |
| [Switzerland](https://specstream.ai/data/clinical-trials/country/switzerland) | 14 | September 10, 2026 |
| [Belgium](https://specstream.ai/data/clinical-trials/country/belgium) | 12 | October 23, 2026 |
| [France](https://specstream.ai/data/clinical-trials/country/france) | 12 | July 16, 2026 |
| [Germany](https://specstream.ai/data/clinical-trials/country/germany) | 10 | September 21, 2026 |
| [Poland](https://specstream.ai/data/clinical-trials/country/poland) | 10 | March 27, 2026 |
| [Denmark](https://specstream.ai/data/clinical-trials/country/denmark) | 9 | October 23, 2026 |
| [Taiwan](https://specstream.ai/data/clinical-trials/country/taiwan) | 9 | September 9, 2026 |
| [Canada](https://specstream.ai/data/clinical-trials/country/canada) | 8 | September 24, 2026 |
| [Austria](https://specstream.ai/data/clinical-trials/country/austria) | 5 | September 30, 2026 |
| [Australia](https://specstream.ai/data/clinical-trials/country/australia) | 4 | October 26, 2026 |
| [Finland](https://specstream.ai/data/clinical-trials/country/finland) | 4 | October 16, 2026 |
| [Pakistan](https://specstream.ai/data/clinical-trials/country/pakistan) | 4 | August 6, 2026 |
| [Norway](https://specstream.ai/data/clinical-trials/country/norway) | 4 | July 22, 2026 |
| [Mexico](https://specstream.ai/data/clinical-trials/country/mexico) | 3 | October 15, 2026 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).